Following a positive ruling on patents and a decision to maintain funding for embryonic stem cell research in Horizon 2020, experts say that things are looking up for regenerative medicine.
Following a positive ruling on patents and a decision to maintain funding for embryonic stem cell research in Horizon 2020, experts say that things are looking up for regenerative medicine.
Receive our news bulletin each Tuesday & Thursday and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
